119 related articles for article (PubMed ID: 23010022)
1. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2013 Jan; 101():215-22. PubMed ID: 23010022
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
Yordanov G; Evangelatov A; Skrobanska R
Colloids Surf B Biointerfaces; 2013 Jul; 107():115-23. PubMed ID: 23466549
[TBL] [Abstract][Full Text] [Related]
3. Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2012 Apr; 92():98-105. PubMed ID: 22154011
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
5. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
Khajavinia A; Varshosaz J; Dehkordi AJ
Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
7. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.
Bootz A; Vogel V; Schubert D; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):369-75. PubMed ID: 15018998
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles.
Hekmatara T; Gelperina S; Vogel V; Yang SR; Kreuter J
J Nanosci Nanotechnol; 2009 Aug; 9(8):5091-8. PubMed ID: 19928187
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.
De Juan BS; Von Briesen H; Gelperina SE; Kreuter J
J Drug Target; 2006 Nov; 14(9):614-22. PubMed ID: 17090397
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.
Xu ZR; Wang WF; Liang XF; Liu ZH; Liu Y; Lin L; Zhu X
J Mol Neurosci; 2015 Apr; 55(4):854-64. PubMed ID: 25326789
[TBL] [Abstract][Full Text] [Related]
12. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
13. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and
Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
[No Abstract] [Full Text] [Related]
15. Optimization of self-assembling properties of fatty acids grafted to methoxy poly(ethylene glycol) as nanocarriers for etoposide.
Varshosaz J; Hasanzadeh F; Eslamdoost M
Acta Pharm; 2012 Mar; 62(1):31-44. PubMed ID: 22472447
[TBL] [Abstract][Full Text] [Related]
16. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
19. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants.
Wu M; Dellacherie E; Durand A; Marie E
Colloids Surf B Biointerfaces; 2009 Feb; 69(1):141-6. PubMed ID: 19147334
[TBL] [Abstract][Full Text] [Related]
20. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model.
Ambruosi A; Gelperina S; Khalansky A; Tanski S; Theisen A; Kreuter J
J Microencapsul; 2006 Aug; 23(5):582-92. PubMed ID: 16980278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
